Indoco Remedies receives Establishment Inspection Report from USFDA

21 Mar 2016 Evaluate

Indoco Remedies has received the Establishment Inspection Report (approval) from US Food and Drug Administration (USFDA) for its solid dosages manufacturing facility at Goa (Plant I).

Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in India. Its products include anti-cold, anti-spasmodic, anti-infective, anti-inflammatory, stomatological, anti-fungal, cough and cold preparation, cardiovascular, multivitamin, anti-bacterial, analgesic, anti-asthamic and anti-spasmodic, anti-hypersensitive toothpaste, anti-septic gel, antibacterial mouthwash and gel products. It also provides contract research and development services.

Indoco Remedies Share Price

208.05 -6.10 (-2.85%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×